How AI is improving early cancer detection: boosting FIT test accuracy, refining risk models, and reducing regional disparities for earlier intervention.
AI’s Impact on Early Cancer Detection: From Better FIT Results to Fairer Care Read More »
How AI diagnostics improve early detection, diagnostic accuracy and predictive analytics to lower readmissions, optimize hospital resources and support personalized care.
AI Diagnostics: Revolutionizing Early Detection and Patient Care Read More »
Tandem Health acquires Dutch speech AI startup Juvoly to cut clinician admin time, scale proven voice-controlled documentation across Europe, and keep data on Dutch servers.
Juvoly Joins Tandem Health: Speech AI Merger to Scale AI Healthcare Across Europe Read More »
Explore IDEXX Laboratories’ AI tools—ImageVue DR50 Plus, IDEXX Cancer Dx Panel, and inVue Dx analyzer—and their impact on veterinary cancer detection and imaging efficiency.
Horizon1000 commits $50M to equip 1,000 clinics with AI tools by 2028, starting with a Rwanda pilot to support overstretched primary care in Sub-Saharan Africa.
Horizon1000: Gates Foundation and OpenAI Back AI-Powered Primary Care in Rwanda Read More »
LIGAND-AI, a €60M international initiative led by Pfizer and SGC with UCL, will publish large protein-ligand datasets and AI models to speed drug discovery for rare, neurological and cancer targets.
LIGAND-AI: €60M Open Science Push Brings AI to Drug Discovery Read More »
How AI can support return-to-work programs, address mental health funding gaps, and improve early disease detection across UK health services.
AI’s Prescription for UK Healthcare: Workforce, Mental Health and Early Detection Read More »
AI-driven drug discovery, lower rates and a looming patent cliff are set to accelerate biotech M&A in 2026. What investors and executives should watch.
AI Fuels Biotech M&A Boom in 2026 Read More »
How the NHS Federated Data Platform, local ICBs and AI tools are shaping demand-capacity monitoring, operational decisions and system-wide improvements.
UK Healthcare and AI: FDP Shortfalls and Practical Operational Gains Read More »
CleaveNet leverages AI to design protease-targeting molecular sensors that reveal cancer signals in urine, opening paths to earlier, lower-cost, decentralized diagnostics.
